DCB-F1

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameDCB-F1
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterferon alpha modulators
TargetsInterferon alpha
Therapy Area/IndicationsHepatitis C
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDevelopment Center for Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDevelopment Center for Biotechnology
Active IndicationsN/A
Inactive IndicationsHepatitis C

Other Information

ATC CodeN/A
Related LinksN/A